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Background: When Staphylococcus aureus is isolated in urine, it is thought to usually represent hematogenous
spread. Because such spread might have special clinical significance, we evaluated predictors and outcomes of
S. aureus bacteriuria among patients with S. aureus bacteremia.
Methods: A case-control study was performed at John H. Stroger Jr. Hospital of Cook County among adult
inpatients during January 2002-December 2006. Cases and controls had positive and negative urine cultures,
respectively, for S. aureus, within 72 hours of positive blood culture for S. aureus. Controls were sampled randomly
in a 1:4 ratio. Univariate and multivariable logistic regression analyses were done.
Results: Overall, 59% of patients were African-American, 12% died, 56% of infections had community-onset
infections, and 58% were infected with methicillin-susceptible S. aureus (MSSA). Among 61 cases and 247 controls,
predictors of S. aureus bacteriuria on multivariate analysis were urological surgery (OR = 3.4, p = 0.06) and
genitourinary infection (OR = 9.2, p = 0.002). Among patients who died, there were significantly more patients with
bacteriuria than among patients who survived (39% vs. 17%; p = 0.002). In multiple Cox regression analysis, death
risks in bacteremic patients were bacteriuria (hazard ratio 2.9, CI 1.4-5.9, p = 0.004), bladder catheter use (2.0,
1.0-4.0, p = 0.06), and Charlson score (1.1, 1.1-1.3, p = 0.02). Neither length of stay nor methicillin-resistant
Staphylococcus aureus (MRSA) infection was a predictor of S. aureus bacteriuria or death.
Conclusions: Among patients with S. aureus bacteremia, those with S. aureus bacteriuria had 3-fold higher
mortality than those without bacteriuria, even after adjustment for comorbidities. Bacteriuria may identify patients
with more severe bacteremia, who are at risk of worse outcomes.
Background
Bacteriuria with Staphylococcus aureus is postulated
to occur through a limited number of mechanisms–
primarily ascending spread after instrumentation (e.g.,
urologic procedures or urethral catheterization) or
hematogenous seeding of the genitourinary tract. The
finding by Lee et al., that bacteremia is strongly asso-
ciated with bacteriuria among patients infected with
S. aureus, supports the notion that bacteremia is an
important precursor for bacteriuria [1]. What is less
clear, however, is whether in patients with S. aureus
bacteremia, the finding of S. aureus in the urine holds
any prognostic significance.
Among patients with S. aureus bacteremia, there are
many prognostic factors, including host factors or
comorbidities (age [2-10], Charlson score [2,11], immu-
nosuppression [4], alcoholism [4], hemodialysis [4],
acute renal failure [4], diabetes mellitus [8], recent hos-
pitalization [11], mechanical ventilation [5], and acute
severity of illness [12]); pathogen-specific factors (MRSA
[3,13] superantigenic toxin production [14]); or charac-
teristics of clinical presentation or management (menin-
gitis [13] or altered mental status [11,12], community-
acquired infection [4], severe sepsis or septic shock
[3,4,6,7], lack of an infectious disease consult [4,15],
prior antibiotic therapy [6], unknown [8] or persisting
foci of infection [16], daily dose of penicillinase-stable
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treatment [6,12] or duration of treatment < 14 days
[16]). The relation of occurrence of bacteriuria to out-
come has been postulated [17], but the interactions with
other risk factors warrant investigation. That bacteriuria
might be a predictor of worse outcome in S. aureus bac-
teremia has biologic plausibility. For example, several
innate defense mechanisms exist that prevent the devel-
opment of urinary tract seeding in bacteremic patients:
defensins, Toll-like receptor 4, and chemokine receptor
CXCR1 [18,19], and these innate defenses may be over-
come and the urinary tract seeded in the setting of
higher bacterial loads [20].
Over the last 20 years, MRSA has emerged as an
important cause of nosocomial bacteremia [21], and sig-
nificant increases in the incidence of MRSA infections
in community patients have been observed in the past
few years [22-24]. Methicillin-resistance is a major risk
for increased morbidity and mortality in S. aureus infec-
tion. Given the increasing burden of infection by com-
munity-associated MRSA (CA-MRSA) infections [22-24]
and the suggestion that CA-MRSA strains may have
greater virulence, predictors of morbidity and mortality
are essential for allocation of clinical infections.
We hypothesized that for patients with S. aureus bac-
teremia, bacteriuria is an important marker of disease
severity and predictor of worse outcomes. We examined
this hypothesis by evaluating outcomes of S. aureus bac-
teremia in patients with and without bacteriuria. We
also examined the impact of methicillin-resistance on
outcomes among patients with S. aureus bacteremia
with and without bacteriuria. Finally, using our cohort,
we examined the predictors of bacteriuria.
Methods
Setting
A case-control study was performed for patients
admitted to John H. Stroger Jr. Hospital of Cook
County, a 464-bed inner-city safety-net hospital in Chi-
cago, Illinois. The institutional review board reviewed
the study and deemed it exempt from review.
Study Design and Definitions
Our study included in-patients during January 2002
through December 2006. Cases were patients who had a
positive urine culture for S. aureus within 72 hours of a
positive blood culture for S. aureus.C o n t r o l sw e r e
patients who had a negative urine culture for S. aureus
within 72 hours of a positive blood culture S. aureus.
Control patients were randomly sampled from all eligi-
ble patients with S. aureus bacteremia but without bac-
teriuria (i.e., with negative urine cultures), with the aim
of 4 controls per case. Subsequently, chart reviews were
performed and exclusion criteria were applied to
sampled putative cases and controls to create a cohort
for analysis.
Patients who were younger than age 18 years, who
were seen only in the emergency department or in the
clinic, or who did not have a urine culture performed
within 72 hours of the positive blood cultures, were
excluded. Only the first episode of S. aureus bacteremia
per admission was assessed.
Using electronic data and chart review, we collected
demographic and clinical data including mortality, ICU
admission, length of stay, age, race, sex, Charlson score
[25], comorbidities (HIV, diabetes mellitus, end stage
renal disease requiring hemodialysis), alcoholism, intra-
venous drug use, presence of indwelling bladder catheter
at the time of culture, previous urological procedure,
duration of fever, duration of bloodstream infection,
urinary symptoms, duration of chief complaint, organs
and sites infected by S. aureus decided by the clinician,
evidence of foreign material, susceptibilities of S. aureus,
and time to appropriate antimicrobial therapy. For
patients who died during their hospitalization, death was
attributed to the bacteremia if so noted by the patient’s
discharge diagnosis or when there was a positive blood
culture within 1 week preceding death.
S. aureus was deemed hospital-acquired if illness had
onset > 72 hours after hospital admission. Cultures that
turned positive within 72 hours of admission–community-
onset–were divided into 2 groups: healthcare-associated
infection was defined based on history of hospitalization,
surgery, dialysis, or residence in a long-term care facility
within 1 year or a presence of an indwelling catheter or
percutaneous medical device (e.g., tracheostomy tube, gas-
trostomy tube, or bladder catheter) or a prior MRSA infec-
tion; patients with community-acquired infection did not
have any of these risk factors [26].
Statistical Methods
Categorical variables were examined with chi-square
analysis and continuous variables were analyzed with
the independent samples t test. For multivariable analy-
sis, statistically important factors with p values <0.10 on
univariate analysis were included in initial models, and
Charlson score was included a priori based on the
strong association between comorbidities and death, and
our desire to appropriately adjust for comorbidities in
our analysis. We used Cox proportional hazards regres-
sion analysis to assess the association of bacteriuria with
time to S. aureus death or hospital discharge, adjusted
for suspected effect modifiers as identified in univariate
analysis. Explanatory variables were evaluated for adher-
ence to the proportional hazards assumption. To assess
the multivariable predictors of bacteriuria, logistic
regression was used. Data analysis was performed using
SPSS software (version 15.0, Chicago, IL).
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During 5 years (January 1, 2002, through December 31,
2006), 67 patients with S. aureus bacteremia and bacter-
iuria were identified, and control sampling yielded 268
bacteremic, non - bacteriuric patients. Following chart
reviews and application of exclusion criteria, there were
61 cases and 247 controls. Of all 308 episodes of bacter-
emia, 128 (41.6%) were due to MRSA.
The mean age of pooled dataset, created by joining
case and control patients was 48.3 years; 68.5% were
male, 181 (58.8%) were African-American, and 37
(12.0%) died during hospital admission. Sites involved
Table 1 Univariate analysis of predictors of death during admission among patients with S. aureus bacteremia and a
contemporaneous urine culture obtained
a
Risk Factor
b Death during admission No death during admission OR (95% CI) P value
N 36 253
Demographics
Male 22 (61) 176 (70) 0.31
Race/Ethnicity 0.46
Black 22 (61) 145 (50)
Hispanic 9 (25) 44 (15)
Other race 2 (6) 23 (8)
White 3 (8) 41 (14)
Age 51.6 (15.8) 47.6 (15.3) 0.15
Microbiological Factors
Epidemiologic risk 0.76
Community associated 11 (31) 69 (27)
Healthcare associated 8 (22) 71 (28)
Hospital onset 17 (47) 113 (45)
MRSA 17 (47) 103 (41) 0.46
Urine culture positive 14 (39) 43 (17) 3.11 (1.47 - 6.55) 0.002
Clinical Factors
HIV 6 (17) 28 (11) 0.32
Bladder catheter 19 (53) 86 (34) 2.17 (1.07 - 4.39) 0.03
Charlson score 2.84 2.04 0.22
Hemodialysis 1 (3) 26 (11) 0.24 (0.03 - 1.90) 0.15
Immunosuppressed 8 (22) 45 (18) 0.52
Urological surgery 0 (0) 13 (5) 0.16
DM 13 (36) 70 (28) 0.30
IVDA 4 (11) 42 (17) 0.40
Prosthetic device 3 (8) 63 (25) 0.27 (0.08-0.92) 0.03
Alcoholism 7 (19) 40 (16) 0.58
ID consult or management
c 18 (50) 128 (60) 0.25
Line/phlebitis 2 (6) 56 (22) 0.21 (0.05-0.89) 0.02
Skin soft tissue infection 7 (19) 50 (20) 0.96
Bone/joint infection 2 (6) 25 (25) 0.40
Pulmonary infection 6 (17) 35 (14) 0.65
GU infection 0 (0) 22 (9) 0.05
Incubation Period 26.8 (67.4) 12.4 (24.0) 0.21
Outcome
Fever days 2.7 (4.8) 3.7 (5.0) 0.11
Time to effective therapy 1.06 (2.6) days 1.8 (3.7) days 0.12
Length of stay after culture 10.1 (11.3) days 13.5 (14.1) days 0.17
Footnotes:
aContemporaneous urine cultures are performed within 72 hours of the blood culture.
bData represent count (%) and mean (standard deviation) for
count and continuous data, respectively.
cPatient management was either primarily by infectious diseases clinician or with infectious diseases consultation.
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catheters [59 (19.2%)], skin/soft tissue [57 (18.5%)],
bone/joints [27 (8.8%)], lungs [41 (13.3%)], genitourinary
tracts [22 (7.1%)], and other sites [11 (3.6%)]; for 106
(36.7%) patients, there was no documented organ invol-
vement other than bloodstream.
Hospital mortality rates were higher in S. aureus bac-
teremia patients with bacteriuria compared to patients
without bacteriuria (39% vs 17%, respectively, p = 0.002)
(table 1). In multiple Cox regression (table 2), significant
predictors of death were positive urine culture (Hazard
ratio 2.9; 95% CI, 1.4-5.9, p = 0.004), indwelling bladder
catheter (2.0; 95% CI, 0.97-4.0, p = 0.06), and Charlson
score (1.2; 95% CI, 1.1-1.3, p = 0.02); vascular catheter
infection or phlebitis was associated with lower risk of
death (0.27; 95% CI, 0.060-1.2, p = 0.09). Cox regression
showed a significantly higher mortality rate in case than
in control patients (figure 1). Neither methicillin-resis-
tance nor the specific strain types of MRSA were predic-
tors of mortality in univariate or multivariable analysis.
More positive urine cultures were seen in community-
onset (both community-acquired and healthcare-asso-
ciated) compared to hospital-acquired bacteremia (46%
vs 23%, respectively, p < 0.001); in HIV-positive patients
compared to HIV-negative patients (19% vs 10%, p =
0.05); and in patients with recent urological surgery
(11% vs 3%, p = 0.03) or genitourinary infection (21% vs
4%, p < 0.001) compared with those without genitourin-
ary problems (table 3). In multivariable analysis (table
4), urological surgery (OR 4.5, p = 0.045) and genitour-
inary infection (OR 5.7, p = 0.002) were significantly
associated with positive urine cultures.
Discussion
In our case-control study, patients who had S. aureus
bacteremia and a positive urine culture for S. aureus
had significantly higher mortality than did bacteremic
patients with a negative urine culture. This was true
even after adjustment for multiple covariates including
use of bladder catheters, presence or absence of lower
urinary tract symptoms, or recent urological surgeries,
which are known risk factors for a positive urine cul-
ture, significant factor in the multivariable analysis such
as presence of line infection or phlebitis or presence of
comorbidities as measured by the Charlson score [2,11].
The conclusion that S. aureus bacteriuria patients have
worse prognosis compared to patients without S. aureus
bacteriuria among S. aureus bacteremia patients may be
useful to clinicians when deciding whether to monitor a
patient on the ward or the ICU and when explaining
the prognosis of the illness to the patient and his family.
S. aureus is a common pathogen in the community
and in hospitals. Sa u r e u scauses significant mortality
and morbidity but is an infrequent cause of urinary
tract infection [27]. In patients with S. aureus bactere-
mia, a positive urine culture is typically attributed to
ascending infection or to hematogenous spread. Predic-
tors of a positive urine culture for S. aureus include pre-
sence of indwelling bladder catheters, urinary tract
obstruction, instrumentation, or surgery [27,28]. We
hypothesized that S. aureus appears in the urine in bac-
teremic patients because of higher burden of organisms
and thus may portend worse outcome.
A recent study examining the relationship of bacter-
iuria with mortality found a two-fold increased risk of
death in patients with concomitant S. aureus bacteriuria
and bacteremia [17]. The current study adds to pub-
lished literature by including significant numbers of
methicillin-resistant isolates and by using statistical
methods appropriate for varying time at risk. The asso-
ciation of bacteriuria with i n c r e a s e dr i s ko fm o r t a l i t y
even after adjustment for comorbidities was similar in
both studies, suggesting that bacteriuria provides useful
prognostic informati o ni nt h es e t t i n go fS. aureus bac-
teremia. In addition, based on our findings, it appears
that this is an effect independent of methicillin-resis-
tance and that secular trends in incidence of MRSA are
unlikely to alter this association.
Figure 1 Cox regression for survival analysis for S. aureus
bacteremia patients with and without bacteriuria (p value =
0.004).
Table 2 Multiple Cox regression analysis of factors
predictive of death among patients with S. aureus
bacteremia with one contemporaneous urine culture
obtained
Risk factor Hazard Ratio (95% CI) P value
Urine culture positive for S. aureus 2.87 (1.411-5.851) 0.004
Bladder catheter present 1.96 (0.966-3.965) 0.063
Line infection/phlebitis 0.268 (0.060-1.199) 0.085
Charlson score 1.183 (1.063-1.316) 0.018
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patients in the study were cared for at a single center
and it may be difficult to generalize our findings to
other hospitals. The Cook County Bureau of Health Ser-
vices is the largest provider of indigent care in Cook
County and has seen large increases in rates of commu-
nity-associated S. aureus infection, and our estimates
likely represent robust measures of risk for mortality. A
second limitation is that this was a retrospective study
and depended on documentation in the chart, which
may have resulted in misclassification errors in assessing
comorbidities and other covariates. Non-differential mis-
classification tends to bias towards the null, which sug-
gests that our estimates of risk are likely conservative.
In addition, electronic data were used in this study and
were prospectively collected at the time of care; these
data were not subject to problems inherent in reviews of
written documentation Finally, in our study, we had an
overall mortality rate of 12% which was at the lower end
of published mortality rates–12-46% [3-13,27,29,30]–in
this setting, suggesting that our cohort may have had
fewer comorbidities and lower attributable mortality
Table 3 Univariate analysis of risk factors for bacteriuria among patients with S. aureus bacteremia
Risk Factor
a Urine culture positive Urine culture negative OR (95% CI) P value
N 57 232
Demographics
Age 49.1 (13.8) 47.9 (13.8) 0.59
Male 40 (70) 158 (68) 0.76
Race/Ethnicity 0.10
Black 26 (46) 141 (61)
Hispanic 14 (25) 39 (17)
Other Race 4 (7) 21 (9)
White 13 (22) 31 (13)
Microbiological factor
Epidemiological Risk
Community onset 26 (46) 54 (23) <0.001
Healthcare associated 18 (32) 61 (26)
Hospital onset 13 (23) 117 (50)
MRSA 21 (37) 99(43) 0.42
Clinical Factors
Immunosuppressed 9 (16) 44 (19) 0.58
Incubation Period 15.7 (30.5) 13.8 (33.4) 0.68
Charlson Score 2.05 2.15 0.801
Hemodialysis 3 (5) 24 (10) 0.24
HIV 11 (19) 23 (10) 2.17 (1.00 - 4.77) 0.05
Endocarditis 7 (12) 17 (7) 0.22
Bladder catheter 20 (35) 85 (37) 0.83
Urological surgery 6 (11) 7 (3) 3.78 (1.22 - 11.73) 0.03
DM 19 (33) 64 (28) 0.39
IVDA 7 (12) 39 (17) 0.40
Prosthetic device 11 (19) 55 (24) 0.48
Alcoholism 11 (19) 36 (16) 0.49
Line infection/phlebitis 6 (11) 52 (22) 0.41 (0.17 - 1.00) 0.05
Skin soft tissue infection 10 (18) 47 (20) 0.64
Bone/joint infection 7 (12) 20 (9) 0.39
Pulmonary infection 12 (21) 29 (13) 1.87 (0.89 - 3.94) 0.10
GU infection 12 (21) 10 (4) 5.92 (2.41 - 14.54) <0.001
Footnotes:
aData represent count (%) and mean(standard deviation) for count and continuous data, respectively.
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significant burden of CA-MRSA in our patient
population.
Conclusions
In patients with S. aureus bacteremia, a positive urine
culture for S. aureus may be used to identify patients at
higher risk of death. Patients who have S. aureus bacter-
emia and more comorbidities are at increased risk for
higher mortality rate.
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